More about
Post-Injection Delirium/Sedation Syndrome
News
May 14, 2024
1 min read
Save
Positive efficacy results reported in phase 3 study of schizophrenia injectable
Teva Pharmaceuticals and Medincell have announced positive efficacy results from the phase 3 SOLARIS clinical trial evaluating an investigational, monthly subcutaneous injectable in adults with schizophrenia.